WallStreetZenWallStreetZen

NYSE: RCUS
Arcus Biosciences Inc Stock Ownership - Who owns Arcus Biosciences?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Arcus Biosciences Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Alexander AzoyChief Accounting Officer2025-09-051,579$11.88
$18.76kSell
Yasunori KanekoDirector2025-02-2720,000$10.06
$201.20kBuy
Terry J. RosenChief Executive Officer2025-02-2719,800$10.18
$201.47kBuy
Gilead Sciences Inc10% Owner2025-02-181,363,636$11.00
$15.00MBuy
Ii Robert C. GoeltzChief Financial Officer2024-12-313,594$15.00
$53.91kSell
Alexander AzoyChief Accounting Officer2024-12-193,007$15.17
$45.62kSell
Terry J. RosenChief Executive Officer2024-12-1537,882$16.08
$609.14kSell
Carolyn C. TangGeneral Counsel2024-12-1511,339$16.08
$182.33kSell
Alexander AzoyChief Accounting Officer2024-12-152,969$16.08
$47.74kSell
Ii Robert C. GoeltzChief Financial Officer2024-12-1510,099$16.08
$162.39kSell

1 of 2

RCUS insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when RCUS insiders and whales buy or sell their stock.

RCUS Shareholders

What type of owners hold Arcus Biosciences Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Gilead Sciences Inc29.53%31,424,760$362.01MInsider
Gilead Sciences Inc29.53%31,424,760$362.01MInstitution
Terry J. Rosen13.84%14,731,646$169.71MInsider
Blackrock Inc10.77%11,457,979$132.00MInstitution
Vanguard Group Inc6.16%6,556,243$75.53MInstitution
Point72 Asset Management LP5.61%5,966,664$68.74MInstitution
Woodline Partners LP3.76%4,000,029$46.08MInstitution
Suvretta Capital Management LLC3.47%3,688,858$42.50MInstitution
State Street Corp3.41%3,630,815$41.83MInstitution
Gv 2016 GP LLC2.94%3,125,312$36.00MInsider

1 of 3

RCUS vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
RCUS63.74%36.26%Net BuyingNet Selling
TRML58.17%41.83%Net BuyingNet Buying
INVA59.68%40.32%Net SellingNet Selling
XERS56.08%15.19%Net SellingNet Selling
GPCR31.63%12.59%Net SellingNet Selling
View Top Biotech Stocks

Arcus Biosciences Stock Ownership FAQ

Who owns Arcus Biosciences?

Arcus Biosciences (NYSE: RCUS) is owned by 93.69% institutional shareholders, 53.29% Arcus Biosciences insiders, and 0.00% retail investors. Gilead Sciences Inc is the largest individual Arcus Biosciences shareholder, owning 31.42M shares representing 29.53% of the company. Gilead Sciences Inc's Arcus Biosciences shares are currently valued at $362.01M.

If you're new to stock investing, here's how to buy Arcus Biosciences stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.